Philipp le Coutre

Philipp le Coutre

UNVERIFIED PROFILE

Are you Philipp le Coutre?   Register this Author

Register author
Philipp le Coutre

Philipp le Coutre

Publications by authors named "Philipp le Coutre"

Are you Philipp le Coutre?   Register this Author

94Publications

2307Reads

27Profile Views

The role of bosutinib in the treatment of chronic myeloid leukemia.

Future Oncol 2020 Jan 13;16(2):4395-4408. Epub 2019 Dec 13.

Department of Medicine & Surgery, University of Milano-Bicocca, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2019-0555DOI Listing
January 2020

Single-cell analysis based dissection of clonality in myelofibrosis.

Nat Commun 2020 Jan 7;11(1):73. Epub 2020 Jan 7.

Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology, and Tumor Immunology, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-019-13892-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946829PMC
January 2020

Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure.

N Engl J Med 2019 12;381(24):2315-2326

From the South Australian Health and Medical Research Institute and the University of Adelaide, Adelaide, SA, Australia (T.P.H., D.Y., D.M.R.); Memorial Sloan Kettering Cancer Center, New York (M.J.M., M.S.T., J.H.P.); University of Texas M.D. Anderson Cancer Center, Houston (J.E.C.); Kobe University Graduate School of Medicine, Kobe (H.M.), and the National Cancer Center Hospital East, Chiba (Y.M.) - both in Japan; Hôpital Saint-Louis, Paris (D.R.), and the University of Bordeaux, Bordeaux (F.-X.M.) - both in France; Dana-Farber Cancer Institute, Boston (D.J.D.); Sapienza University, Rome (M.B.); Singapore General Hospital, Singapore (Y.-T.G.); University of Michigan Comprehensive Cancer Center, Ann Arbor (M.T.); Universitätsklinikum Jena, Jena (A.H.), Charité Hospital, Berlin (P.C.), and the Department for Hematology-Oncology, Goethe University Hospital, Frankfurt am Main (F.L.) - all in Germany; University of Cardiff, Cardiff, United Kingdom (O.O.); Veterans Affairs Portland Health Care System (M.C.H.) and Oregon Health and Science University Knight Cancer Institute (M.C.H., B.J.D.), Portland; Hospital de la Princesa and Instituto de Investigación Sanitaria Princesa, Madrid (J.L.S.); Huntsman Cancer Institute, University of Utah, Salt Lake City (M.W.N.D.); Amsterdam University Medical Centers, VU University Medical Center, Amsterdam (J.J.W.M.J.); Novartis Pharma, Basel, Switzerland (D.H., Y.D., C.M., F.H.-P., K.G.V.); and Seoul St. Mary's Hematology Hospital, Catholic University of Korea, Seoul, South Korea (D.-W.K.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1902328DOI Listing
December 2019

HLA class I-restricted T cell epitopes isolated and identified from myeloid leukemia cells.

Sci Rep 2019 Oct 1;9(1):14029. Epub 2019 Oct 1.

Department of Dermatology, Venerology and Allergology, Clinical Research Group 'Tumor Immunology', Charité - Universitätsmedizin Berlin corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10098, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-019-50341-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773711PMC
October 2019

Nilotinib.

Recent Results Cancer Res 2018;212:69-85

Division of Hematology and Oncology, Medical Department, Charité Universitätsmedizin Berlin, Campus Charité Mitte, Charitéplatz 1, 10117, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-319-91439-8_3DOI Listing
May 2019

Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial.

J Clin Oncol 2018 01 1;36(3):231-237. Epub 2017 Nov 1.

Jorge E. Cortes, University of Texas MD Anderson Cancer Center, Houston, TX; Carlo Gambacorti-Passerini, University of Milano-Bicocca, Monza, Italy; Michael W. Deininger, University of Utah, Salt Lake City, UT; Michael J. Mauro, Memorial Sloan Kettering Cancer Center, New York, NY; Charles Chuah, Singapore General Hospital, Duke-National University of Singapore Medical School, Singapore, Singapore; Dong-Wook Kim, Seoul St Mary's Hospital, The Catholic University of Korea, Seoul, South Korea; Irina Dyagil, National Research Center for Radiation Medicine, Kiev; Nataliia Glushko, Ivano-Frankivsk Regional Clinical Hospital, Ivano-Frankivsk, Ukraine; Dragana Milojkovic, Imperial College London at Hammersmith Hospital London; Laurence Reilly and Allison Jeynes-Ellis, Avillion, London, United Kingdom; Philipp le Coutre, Charité-Universitätsmedizin Berlin, Berlin; Andreas Hochhaus, Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena; Tim H. Brümmendorf, Universitätsklinikum RWTH Aachen, Aachen, Germany; Valentin Garcia-Gutierrez, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain; Eric Leip, Pfizer, Cambridge, MA; Nathalie Bardy-Bouxin, Pfizer International Operation, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.7162DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966023PMC
January 2018

Predictive significance of the European LeukemiaNet classification of genetic aberrations in patients with acute myeloid leukaemia undergoing allogeneic stem cell transplantation.

Eur J Haematol 2017 Feb 22;98(2):160-168. Epub 2016 Oct 22.

Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12815DOI Listing
February 2017

Longitudinal Study to Assess the Clinical Significance of MSI2 Expression in Chronic Myeloid Leukemia Patients.

Acta Haematol 2016 10;136(1):62-4. Epub 2016 May 10.

Charitx00E9; - Universitx00E4;tsmedizin Berlin, Campus Virchow Klinikum, Medizinische Klinik m.S. Hx00E4;matologie und Onkologie, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000445097DOI Listing
December 2016

Allogeneic stem cell transplantation for refractory acute myeloid leukemia: a single center analysis of long-term outcome.

Eur J Haematol 2015 Dec 24;95(6):498-506. Epub 2015 Mar 24.

Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12522DOI Listing
December 2015

Emerging Role of Tyrosine Kinases as Drugable Targets in Cancer.

Biomark Insights 2015 10;10(Suppl 3):29-31. Epub 2015 Sep 10.

Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/BMI.S22432DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567050PMC
September 2015

Impact of early remission by induction therapy on allogeneic stem cell transplantation for acute myeloid leukemia with an intermediate-risk karyotype in first complete remission.

Eur J Haematol 2015 May 11;94(5):431-8. Epub 2014 Oct 11.

Department of Hematology, Oncology and Tumorimmunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12449DOI Listing
May 2015

Differential expression of SHP-1 in chronic myeloid leukemia.

Leuk Lymphoma 2015 May 30;56(5):1547-9. Epub 2014 Oct 30.

Hämatologie, Onkologie und Tumorimmunologie, Medizinische Klinik m.S., Campus Virchow Klinikum, Charité, Universitätsmedizin Berlin , Berlin , Germany.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.3109/10428194.2014.96
Publisher Site
http://dx.doi.org/10.3109/10428194.2014.969258DOI Listing
May 2015

BCR-ABL1(+) acute myeloid leukemia: clonal selection of a BCR-ABL1(-) subclone as a cause of refractory disease with nilotinib treatment.

Acta Haematol 2015 12;133(2):237-41. Epub 2014 Nov 12.

Department of Hematology, Oncology and Tumor Immunology, Charité-University Medicine Berlin, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000368176DOI Listing
April 2015

Vascular safety issues in CML patients treated with BCR/ABL1 kinase inhibitors.

Blood 2015 Feb 18;125(6):901-6. Epub 2014 Dec 18.

Medical Clinic for Hematology and Oncology, Campus Virchow, Charité, Medical University of Berlin, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-09-594432DOI Listing
February 2015

Clinical lessons to be learned from patients developing chronic myeloid leukemia while on immunosuppressive therapy after solid organ transplantation: yet another case after orthotopic heart transplantation.

Case Rep Hematol 2014 16;2014:890438. Epub 2014 Nov 16.

Medizinische Klinik mit Schwerpunkt Hämatologie und Onkologie, Universitätsmedizin Berlin, Campus Mitte Charité, Schumannstraße 20/21, 10117 Berlin, Germany ; Medizinische Klinik mit Schwerpunkt Hämatologie, Onkologie und Tumorimmunologie, Universitätsmedizin Berlin, Campus Virchow Charité, Augustenburger Platz 1, 13353 Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2014/890438DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4248424PMC
December 2014

Comparison of chimerism and minimal residual disease monitoring for relapse prediction after allogeneic stem cell transplantation for adult acute lymphoblastic leukemia.

Biol Blood Marrow Transplant 2014 Oct 4;20(10):1522-9. Epub 2014 Jun 4.

Department of Hematology, Oncology and Tumor Immunology, Charité-University Medicine Berlin, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.05.026DOI Listing
October 2014

Effects of Jak2 type 1 inhibitors NVP-BSK805 and NVP-BVB808 on Jak2 mutation-positive and Bcr-Abl-positive cell lines.

Acta Haematol 2014 31;132(1):75-86. Epub 2014 Jan 31.

Medizinische Klinik m.S. Hämatologie und Onkologie, Campus Virchow Klinikum, Charité, Universitätsmedizin Berlin, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000356784DOI Listing
September 2014

Nilotinib.

Recent Results Cancer Res 2014 ;201:67-80

Campus Virchow-Klinikum, Medical Department, Division of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-642-54490-3_3DOI Listing
September 2014

Elevated incidence of chronic myeloid leukaemia in immunosuppressed solid organ transplant recipients.

Br J Haematol 2014 Aug 4;166(4):619-21. Epub 2014 Apr 4.

Division of Hematology/Oncology, Department of Medicine, Loyola University Medical Center, Maywood, IL, USA; Division of Hematology/Oncology, Department of Medicine, University of Florida, Gainesville, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12885DOI Listing
August 2014

Inhibition of c-Kit signaling is associated with reduced heat and cold pain sensitivity in humans.

Pain 2014 Jul 21;155(7):1222-8. Epub 2014 Mar 21.

Max-Delbrück-Center for Molecular Medicine, Berlin, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pain.2014.03.010DOI Listing
July 2014

OCT1 genetic variants are associated with long term outcomes in imatinib treated chronic myeloid leukemia patients.

Eur J Haematol 2014 Apr 18;92(4):283-8. Epub 2013 Dec 18.

Division of Hematology, Chaim Sheba Medical Center, Tel Hashomer, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12235DOI Listing
April 2014

Cytogenetic risk grouping by the monosomal karyotype classification is superior in predicting the outcome of acute myeloid leukemia undergoing allogeneic stem cell transplantation in complete remission.

Eur J Haematol 2014 Feb 21;92(2):102-10. Epub 2013 Nov 21.

Department of Hematology, Oncology and Tumorimmunology, Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12216DOI Listing
February 2014

Nilotinib population pharmacokinetics and exposure-response analysis in patients with imatinib-resistant or -intolerant chronic myeloid leukemia.

Eur J Clin Pharmacol 2013 Apr 5;69(4):813-23. Epub 2012 Oct 5.

HRB Clinical Research Facility, Galway, and Trinity College, National University of Ireland, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00228-012-1385-4DOI Listing
April 2013

Off-target effects of BCR-ABL1 inhibitors and their potential long-term implications in patients with chronic myeloid leukemia.

Leuk Lymphoma 2012 Dec 18;53(12):2351-61. Epub 2012 Jun 18.

Department of Hematology and Advanced Oncohematologic Therapies Group IIS-IP, Hospital Universitario de La Princesa, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2012.695779DOI Listing
December 2012

Clinical cardiac safety profile of nilotinib.

Haematologica 2012 Jun 22;97(6):883-9. Epub 2012 Jan 22.

Medizinische Klinik mS Hämatologie und Onkologie, Charité -Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2011.058776DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3366654PMC
June 2012

Tyrosine kinase inhibitors noncompetitively inhibit MCT8-mediated iodothyronine transport.

J Clin Endocrinol Metab 2012 Jan 26;97(1):E100-5. Epub 2011 Oct 26.

Institut für Experimentelle Endokrinologie, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2011-1837DOI Listing
January 2012

Omacetaxine mepesuccinate for the treatment of leukemia.

Expert Opin Pharmacother 2011 Oct;12(15):2381-92

Medizinische Klinik m.S. Hämatologie und Onkologie, Charité-Universitätsmedizin Berlin, Campus Virchow-Klinikum, Augustenburger Platz 1, 13353 Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2011.613378DOI Listing
October 2011

Post-transplantation chronic myeloid leukemia.

Clin Adv Hematol Oncol 2011 Aug;9(8):627-9

Medizinische Klinik m.S. Hämatologie und Onkologie, Campus Virchow Klinikum, Charité, Universitätsmedizin Berlin, Germany.

View Article

Download full-text PDF

Source
August 2011

A modified EBMT risk score predicts the outcome of patients with acute myeloid leukemia receiving allogeneic stem cell transplants.

Eur J Haematol 2011 Apr;86(4):305-16

Department of Hematology, Oncology and Tumorimmunology, Charité- Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0609.2011.01580.xDOI Listing
April 2011

The expanding role of nilotinib in chronic myeloid leukemia.

Expert Opin Drug Saf 2011 Jan 2;10(1):97-107. Epub 2010 Dec 2.

Medizinische Klinik m.S. Hämatologie und Onkologie, Charité-Universitätsmedizin Berlin, Campus Virchow-Klinikum, Augustenburger Platz 1, Berlin, Germany.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1517/14740338.2011.53
Publisher Site
http://dx.doi.org/10.1517/14740338.2011.532486DOI Listing
January 2011

Nilotinib is superior to imatinib as first-line therapy of chronic myeloid leukemia: the ENESTnd study.

Expert Rev Hematol 2010 Dec 9;3(6):665-73. Epub 2010 Nov 9.

HRB Clinical Research Facility, National University of Ireland, Galway & Trinity College, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/ehm.10.61DOI Listing
December 2010

Impact of additional chromosomal aberrations and BCR-ABL kinase domain mutations on the response to nilotinib in Philadelphia chromosome-positive chronic myeloid leukemia.

Haematologica 2010 Apr 16;95(4):582-8. Epub 2009 Dec 16.

Klinik für Hämatologie und Onkologie, Charité - Universitätsmedizin Berlin, Campus Virchow- Klinikum, Augustenburger Platz 1, 13353 Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2009.014712DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2857187PMC
April 2010

Reduced intensity conditioning prior to allogeneic stem cell transplantation in first complete remission is effective in patients with acute myeloid leukemia and an intermediate-risk karyotype.

Int J Hematol 2010 Apr 25;91(3):436-45. Epub 2010 Feb 25.

Department of Hematology and Oncology, Charité, Universitätsmedizin Berlin, Campus Virchow-Klinikum, Augustenburger Platz 1, 13353 Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-010-0515-yDOI Listing
April 2010

Nilotinib.

Recent Results Cancer Res 2010 ;184:103-17

Medizinische Klinik m.S Hämatologie und Onkologie, Charité-Universitätsmedizin Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-642-01222-8_8DOI Listing
March 2010

New developments in tyrosine kinase inhibitor therapy for newly diagnosed chronic myeloid leukemia.

Clin Cancer Res 2010 Mar 2;16(6):1771-80. Epub 2010 Mar 2.

Campus Virchow Klinikum, Charité Universitätsmedizin, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-09-2760DOI Listing
March 2010

BCR-ABL positive cells and chronic myeloid leukemia in immune suppressed organ transplant recipients.

Eur J Haematol 2010 Jan 3;84(1):26-33. Epub 2009 Oct 3.

Medizinische Klinik mit Schwerpunkt Hämatologie und Onkologie, Universitätsmedizin Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0609.2009.01357.xDOI Listing
January 2010

Nilotinib for the treatment of chronic myeloid leukemia.

Expert Rev Hematol 2008 Oct;1(1):29-39

Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum, Medizinische Klinik m.S. Hämatologie und Onkologie, Augustenburger Platz 1, 13353 Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474086.1.1.29DOI Listing
October 2008

Cetuximab: appraisal of a novel drug against colorectal cancer.

Recent Results Cancer Res 2007 ;176:135-43

Centrum für Tumormedizin, Medizinische Klinik mit Schwerpunkt Hämatologie und Onkologie, Charité Campus Virchow-Klinikum, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-540-46091-6_11DOI Listing
July 2007

Vaccination with autologous non-irradiated dendritic cells in patients with bcr/abl+ chronic myeloid leukaemia.

Br J Haematol 2007 May 4;137(4):297-306. Epub 2007 Apr 4.

Department of Haematology and Oncology, Charité, University Medicine Berlin, Campus Virchow-Klinikum, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2007.06547.xDOI Listing
May 2007

Simultaneous cytokine analysis by cytometric bead array for the detection of leukaemia-reactive T cells in patients with chronic myeloid leukaemia.

Br J Haematol 2006 Jan;132(1):32-5

Department of Haematology and Oncology, Charité- University Medicine Berlin, Campus Virchow-Klinikum, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2005.05844.xDOI Listing
January 2006

Unusual sarcomatoid neoplasm of the lung suggesting a myofibrosarcoma.

Virchows Arch 2005 Dec 13;447(6):990-5. Epub 2005 Sep 13.

Institut für Pathologie, Charité Universitätsmedizin Berlin, Schumannstrasse 20/21, 10117 Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00428-005-0043-yDOI Listing
December 2005

Imatinib mesylate radiosensitizes human glioblastoma cells through inhibition of platelet-derived growth factor receptor.

Blood Cells Mol Dis 2005 Mar-Apr;34(2):181-5

Medizinische Klinik für Hämatologie und Onkologie, Campus Virchow, Charité, Humboldt Universität, Augustenburger Platz 1, 13353 Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcmd.2004.11.006DOI Listing
September 2005

Nonmyeloablative stem cell transplantation in patients with ALL and AML results in low nonrelapse mortality despite high rate of infections and GVHD.

Hematol J 2004 ;5(5):395-402

Department of Hematology and Oncology, University Hospital Charité, Campus Virchow-Klinikum, Augustenburger Platz 1, 13353 Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.thj.6200543DOI Listing
March 2005

Quantitative RT-PCR of Wilms tumor gene transcripts (WT1) for the molecular monitoring of patients with accelerated phase bcr/abl + CML.

Leuk Res 2005 Mar;29(3):343-5

Medizinische Klinik m.S. Hämatologie und Onkologie, Campus Virchow-Klinikum, Charité Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2004.08.003DOI Listing
March 2005

Pharmacokinetics and cellular uptake of imatinib and its main metabolite CGP74588.

Cancer Chemother Pharmacol 2004 Apr 5;53(4):313-23. Epub 2003 Dec 5.

Medizinische Klinik für Hämatologie und Onkologie, Campus Virchow, Charité, Humboldt Universität Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-003-0741-6DOI Listing
April 2004

Filgrastim-induced stem cell mobilization in chronic myeloid leukaemia patients during imatinib therapy: safety, feasibility and evidence for an efficient in vivo purging.

Br J Haematol 2004 Jan;124(2):195-9

Medizinische Klinik m.S. Hämatologie und Onkologie, Campus Virchow-Klinikum, Universitätsklinikum Charité, Humboldt-Universität zu Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1365-2141.2003.04756.xDOI Listing
January 2004

Squamous cutaneous epithelial cell carcinoma in two CML patients with progressive disease under imatinib treatment.

Eur J Haematol 2003 Apr;70(4):231-4

Medizinische Klinik mit Schwerpunkt Hämatologie und Onkologie, Campus Virchow, Charité, Humboldt Universität Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1034/j.1600-0609.2003.00044.xDOI Listing
April 2003

Sensitivity to imatinib but low frequency of the TEL/PDGFRbeta fusion protein in chronic myelomonocytic leukemia.

Haematologica 2003 Apr;88(4):408-15

Oncogenic Fusion Protein Unit, Department of Experimental Oncology, Istituto Nazionale Tumori, 20133 Milan, Italy.

View Article

Download full-text PDF

Source
April 2003

Imatinib-induced acute generalized exanthematous pustulosis (AGEP) in two patients with chronic myeloid leukemia.

Eur J Haematol 2002 Oct;69(4):254-6

Medizinische Klinik m. S. Hämatologie und Onkologie, Universitätsklinikum Charité, Campus Virchow-Klinikum, Humboldt-Universität zu Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1034/j.1600-0609.2002.02830.xDOI Listing
October 2002